Summary
Boston Scientific Corporation (BSX) has filed a Form 8-K on October 21, 2008, primarily to announce its third-quarter financial results for the period ended September 30, 2008. The key takeaway for investors is the release of this financial information, which is provided via an attached press release (Exhibit 99.1). This filing serves as the official notification of the Company's performance during the quarter, enabling investors to assess operational progress and financial standing. While the 8-K itself is brief, it directs investors to the accompanying press release for detailed financial figures and management commentary. Investors should review this press release for crucial data such as revenue, earnings per share, net income, and any segment-specific performance. The information is furnished and not deemed 'filed' for certain SEC liability purposes, a standard disclosure for earnings releases included in 8-Ks.
Key Highlights
- 1Boston Scientific Corporation (BSX) announced its third-quarter 2008 financial results via an 8-K filing on October 21, 2008.
- 2The press release detailing the Q3 2008 financial performance is furnished as Exhibit 99.1 to the 8-K.
- 3Investors can find specific financial results, including revenue and earnings, within the attached press release.
- 4The filing formally documents the release of the Company's operational and financial condition for the quarter ended September 30, 2008.
- 5The information provided is furnished and not considered 'filed' under Section 18 of the Exchange Act, meaning it does not carry the same liabilities.